Mankind Pharma share price
You have to be logged in to add this to Watchlist.- ₹2,121.65(-2.50%)January 19, 2026 12:17:06 PM IST
- NSE
- BSE
- Vol : 146.21 K (NSE + BSE)Last 20 day avg : 347.53 K
Mankind Pharma is trading -2.50% lower at Rs 2,121.65 as compared to its last closing price. Mankind Pharma has been trading in the price range of 2,165.70 & 2,121.65. Mankind Pharma has given -0.96% in this year & -3.79% in the last 5 days. Mankind Pharma has TTM P/E ratio 57.24 as compared to the sector P/E of 22.30.There are 16 analysts who have initiated coverage on Mankind Pharma. There are 5 analysts who have given it a strong buy rating & 5 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.The company posted a net profit of 511.51 Crores in its last quarter.Listed peers of Mankind Pharma include Divi's Laboratories (-1.65%), Dr Reddy's Laboratories (-0.34%), Torrent Pharmaceuticals (1.69%).The Mutual Fund holding in Mankind Pharma was at 9.30% in 31 Dec 2025. The MF holding has increased from the last quarter. The FII holding in Mankind Pharma was at 11.34% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 19, 2026, 06:48 AM UTC
- Debt To EquityHigher than industry0.59The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.04Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation4.74The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Bearish | 6,130.95 | -1.65 | 1,62,757.46 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Bearish | 1,171.55 | -0.34 | 97,768.23 | 18.63 | 3.14 | 0.63 | 2.34 |
| Torrent Pharmaceuticals | Bullish | 4,086.85 | 1.69 | 1,38,312.02 | 67.32 | 17.1 | 0.83 | 17.62 |
| Cipla | Bearish | 1,391.80 | -0.44 | 1,12,385.48 | 22.95 | 3.87 | 0.87 | 0.81 |
| Sun Pharmaceutical Industries | Bearish | 1,679.50 | 0.62 | 4,02,958.82 | 36.24 | 5.77 | 0.92 | 0.50 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-03 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-07-31 | Quarterly Results & Interim Dividend |
| 2025-05-21 | Audited Results |
| 2025-01-23 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE634S01028
- BSE Code543904
- NSE CodeMANKIND
Mankind Pharma is trading at 2121.65 as on Mon Jan 19 2026 06:47:06. This is -2.50% lower as compared to its previous closing price of 2176.15.
The market capitalization of Mankind Pharma is 87687.56 Cr as on Mon Jan 19 2026 06:47:06.
The average broker rating on Mankind Pharma is Buy. The breakup of analyst rating is given below -
- 5 analysts have given a strong buy rating
- 5 analysts have given a buy rating
- 4 analysts have given a hold rating
- 2 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Mankind Pharma is 2753.95 whereas the 52 wk low is 2090.10
Mankind Pharma can be analyzed on the following key metrics -
- TTM P/E: 57.24
- Sector P/E: 22.30
- Dividend Yield: 0.05%
- D/E ratio: 0.55
Mankind Pharma reported a net profit of 1990.96 Cr in 2025.
The Mutual Fund Shareholding was 9.30% at the end of 31 Dec 2025.
EQUITY QUICK LINKS
Mankind Pharma QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.